NCT05686447View on ClinicalTrials.gov

Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

June 1, 2026

Study Completion Date

July 31, 2026

Conditions
Monoclonal GammopathiesMultiple MyelomaM-protein
Interventions
OTHER

Observational studies, no intervention

Observational studies, no intervention

Trial Locations (1)

510000

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

All Listed Sponsors
collaborator

National Natural Science Foundation of China

OTHER_GOV

lead

Zhujiang Hospital

OTHER